On May 07, 2026, GMED reported earnings of 1.12 USD per share (EPS) for Q1 26, beating the estimate of 0.93 USD, resulting in a 19.39% surprise. Revenue reached 759.85 million, compared to an expected 751.74 million, with a 1.08% difference. The market reacted with a -8.37% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of 1.11 USD, with revenue projected to reach 798.53 million USD, implying an decrease of -0.89% EPS, and increase of 5.09% in Revenue from the last quarter.